RIMMA GOLUB: Open Payments
NPI 1194325084 · WEST HOLLYWOOD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,499 in 66 payments from 16 companies in 2025. Trend: 2023 $6,720 · 2024 $2,003 · 2025 $1,499
Food & beverage: $1,499
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 20 | $281 |
| ABBVIE INC. | 10 | $244 |
| Lundbeck LLC | 8 | $214 |
| Eisai Inc. | 6 | $193 |
| Lilly USA, LLC | 5 | $132 |
| Sumitomo Pharma America, Inc. | 3 | $77 |
| Aimmune Therapeutics, Inc. | 3 | $73 |
| Boston Scientific Corporation | 1 | $58 |
| OPKO Pharmaceuticals, LLC | 3 | $52 |
| Calliditas Therapeutics US Inc. | 1 | $33 |
Products named: EVENITY, VYEPTI, Leqembi, CREON, GEMTESA, ZENPEP, KISUNLA, LINZESS.
Industry payments across CA — which companies pay providers there.
